Literature DB >> 24423645

Gene disruption of Mfsd8 in mice provides the first animal model for CLN7 disease.

Markus Damme1, Laura Brandenstein2, Susanne Fehr3, Wanda Jankowiak4, Udo Bartsch5, Michaela Schweizer6, Irm Hermans-Borgmeyer7, Stephan Storch8.   

Abstract

Mutations in the major facilitator superfamily domain containing 8 (MFSD8) gene coding for the lysosomal CLN7 membrane protein result in CLN7 disease, a lysosomal storage disease of childhood. CLN7 disease belongs to a group of inherited disorders, called neuronal ceroid lipofuscinoses (NCL), which are characterized by the accumulation of autofluorescent ceroid lipopigments, neuroinflammation, photoreceptor- and neurodegeneration. We have disrupted the Mfsd8 gene by insertion of a lacZ gene-trap cassette between exons 1 and 2 in mice and have analyzed the impact of Cln7 depletion on neuronal and visceral tissues. Analysis of lacZ reporter gene activity in heterozygous Mfsd8((wt/tm1a)) mice showed strong Mfsd8 mRNA expression in the cerebral cortex, in the hippocampus and in the kidney. Homozygous Mfsd8((tm1a/tm1a)) mice were viable and fertile and resembled biochemically the NCL-phenotype of human CLN7 patients including the accumulation of autofluorescent material in the brain and peripheral tissues and of subunit c of mitochondrial ATP synthase in the cerebellum and nuclei of distinct brain regions, and the degeneration of photoreceptor cells in the retina. Lysosomal storage was found in large neurons of the medulla, the hippocampus and in Purkinje cells of the cerebellum in mutant mice. The ultrastructure of the storage material revealed dense lamellar bodies with irregular forms within cerebellar and hippocampal neurons. In the brain loss of Cln7 was accompanied by mild reactive microgliosis and subtle astrogliosis by 10months of age, respectively. In summary we have generated a mouse model which is partly valuable as some but not all neuropathological features of human CLN7 disease are recapitulated thus representing an animal model to study CLN7-specific disease mechanisms.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CLN7 disease; CLN7/MFSD8; Cln7 mouse; Lysosomal membrane protein; Lysosomal storage disease; Lysosomes; Major facilitator superfamily; NCL; Neuronal ceroid lipofuscinosis

Mesh:

Substances:

Year:  2014        PMID: 24423645     DOI: 10.1016/j.nbd.2014.01.003

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  18 in total

1.  A mixed breed dog with neuronal ceroid lipofuscinosis is homozygous for a CLN5 nonsense mutation previously identified in Border Collies and Australian Cattle Dogs.

Authors:  Natalie A Villani; Garrett Bullock; Jennifer R Michaels; Osamu Yamato; Dennis P O'Brien; Tendai Mhlanga-Mutangadura; Gary S Johnson; Martin L Katz
Journal:  Mol Genet Metab       Date:  2019-04-17       Impact factor: 4.797

2.  Mfsd8 Modulates Growth and the Early Stages of Multicellular Development in Dictyostelium discoideum.

Authors:  Shyong Quan Yap; William D Kim; Robert J Huber
Journal:  Front Cell Dev Biol       Date:  2022-06-09

3.  Advances in the Treatment of Neuronal Ceroid Lipofuscinosis.

Authors:  Jonathan B Rosenberg; Alvin Chen; Stephen M Kaminsky; Ronald G Crystal; Dolan Sondhi
Journal:  Expert Opin Orphan Drugs       Date:  2019-11-27       Impact factor: 0.694

Review 4.  Glial Dysfunction and Its Contribution to the Pathogenesis of the Neuronal Ceroid Lipofuscinoses.

Authors:  Keigo Takahashi; Hemanth R Nelvagal; Jenny Lange; Jonathan D Cooper
Journal:  Front Neurol       Date:  2022-04-04       Impact factor: 4.086

5.  A rare homozygous MFSD8 single-base-pair deletion and frameshift in the whole genome sequence of a Chinese Crested dog with neuronal ceroid lipofuscinosis.

Authors:  Juyuan Guo; Dennis P O'Brien; Tendai Mhlanga-Mutangadura; Natasha J Olby; Jeremy F Taylor; Robert D Schnabel; Martin L Katz; Gary S Johnson
Journal:  BMC Vet Res       Date:  2015-01-03       Impact factor: 2.741

6.  Retinal Degeneration In A Mouse Model Of CLN5 Disease Is Associated With Compromised Autophagy.

Authors:  Henri Leinonen; Velta Keksa-Goldsteine; Symantas Ragauskas; Philip Kohlmann; Yajuvinder Singh; Ekaterina Savchenko; Jooseppi Puranen; Tarja Malm; Giedrius Kalesnykas; Jari Koistinaho; Heikki Tanila; Katja M Kanninen
Journal:  Sci Rep       Date:  2017-05-09       Impact factor: 4.379

7.  The Novel Membrane-Bound Proteins MFSD1 and MFSD3 are Putative SLC Transporters Affected by Altered Nutrient Intake.

Authors:  Emelie Perland; Sofie V Hellsten; Emilia Lekholm; Mikaela M Eriksson; Vasiliki Arapi; Robert Fredriksson
Journal:  J Mol Neurosci       Date:  2016-12-16       Impact factor: 3.444

8.  Loss of CLN7 results in depletion of soluble lysosomal proteins and impaired mTOR reactivation.

Authors:  Tatyana Danyukova; Khandsuren Ariunbat; Melanie Thelen; Nahal Brocke-Ahmadinejad; Sara E Mole; Stephan Storch
Journal:  Hum Mol Genet       Date:  2018-05-15       Impact factor: 6.150

9.  A tailored Cln3Q352X mouse model for testing therapeutic interventions in CLN3 Batten disease.

Authors:  Logan Langin; Tyler B Johnson; Attila D Kovács; David A Pearce; Jill M Weimer
Journal:  Sci Rep       Date:  2020-06-29       Impact factor: 4.379

10.  Discovery of a CLN7 model of Batten disease in non-human primates.

Authors:  Jodi L McBride; Martha Neuringer; Betsy Ferguson; Steven G Kohama; Ian J Tagge; Robert C Zweig; Laurie M Renner; Trevor J McGill; Jonathan Stoddard; Samuel Peterson; Weiping Su; Larry S Sherman; Jacqueline S Domire; Rebecca M Ducore; Lois M Colgin; Anne D Lewis
Journal:  Neurobiol Dis       Date:  2018-07-23       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.